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Abstract
We have developed a new samarium diiodide-mediated elimination/isomerization
reaction of benzoyl esters, capable of delivering olefinic products with high yield and
selectivity depending on substrate structure and the additives used. The ability to selectively
synthesize terminal, non-conjugated alkene substituents inspired us to use these optimized
conditions in order to complete the total synthesis of the natural product, honokiol. Honokiol
is a biaryl natural product isolated from magnolia trees that displays desirable oncological
properties as evidenced by several biological studies in recent years. We found that our initially
proposed pathway for completing the synthesis of honokiol was not a feasible route due to the
sensitivity of the allylic groups. However, after adjusting our synthetic route, we were able to
complete the synthesis of honokiol in 40% overall yield.
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Chapter 1. Introduction

1.1 Exploring the Scope of Samarium Diiodide
Samarium diiodide (SmI2) has become one of the most widely used chemical
reagents in the last few decades because it is an incredibly versatile tool. This single
electron transfer (SET) reductant is capable of high levels of chemo-, regio-, and
stereoselectivity depending on the conditions with which it is used. The adaptability of
samarium diiodide is what has made it so prevalent in many different critical steps of
synthetic pathways.
SmI2 is typically prepared as a solution in THF (often 0.1M).1 In the presence of
THF, it has been shown that SmI2 has a coordination number of seven. SmI2 has a
pentagonal bipyramidal molecular geometry, with the iodides along the z-axis and 5 THF
molecules ligated in a planar fashion (Figure 1-1).2 The angles between the planar ligands
tend to distort as the THF molecules are replaced by co-solvents and additives. Many of
the substrates and additives used in SmI2 mediated reactions are capable replacing the THF
ligands and coordinating to Samarium, particularly oxygen-containing compounds due to
samarium’s highly oxophilic nature.1,3 In fact, high equivalents (i.e. 10 equiv or greater) of
very strongly coordinating compounds, such as water or HMPA, will effectively saturate
the inner coordination sphere, leaving the reaction substrate incapable of coordination of
samarium.1 Studies suggest the saturation of the inner coordination sphere leads to outer
sphere electron transfer to the reaction substrate.3 However, more weakly coordinating
additives such as methanol will replace the THF ligands but can still be replaced by the
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reaction substrate to allow for inner sphere electron transfer.1-3 This coordination or lack
thereof can effect selectivity dramatically.1

Figure 1-1. The Molecular Configuration of SmI2(THF)5 as Determined by Evans
and Coworkers2

One of the ways in which samarium diiodide has been recently utilized is to mediate
the classical Julia Olefination reaction (Scheme 1-1). This reaction was first introduced in
1973 as a powerful carbon-carbon bond forming reaction for selectively synthesizing trans
alkenes.4 Traditionally a Na/Hg amalgam had been used for the reductive elimination of
the β-acyloxysulfone, but SmI2 can be used as a less toxic substitute. Keck and Markó first
reported the use of SmI2 in the mid-1990’s for the reductive elimination of
acetyloxysulfones and benzoyloxysulfones respectively.5,6 While similar, the mechanisms
for these processes occur via different discrete steps (vide infra).

2

Scheme 1-1. Julia Olefination

There are two proposed mechanisms for the samarium-promoted reductive
elimination step of the Julia olefination (Scheme 1-2). The first, proposed by Keck, begins
with a SET to the sulfur-oxygen double bond of the sulfone, resulting ultimately in the
formation of the carbon radical after loss of the sulfone group. A second SET then forms a
carbanion, which collapses and eliminates the acetyl ester to form the trans alkene product.5
Because the carbanion intermediate is free to rotate around the carbon-carbon bond, the
intermediate will have the thermodynamically preferred arrangement where the R-groups
are anti-coplanar, which will then lead to selectivity for the trans alkene product. The
second, proposed by Marko and coworkers, begins with a SET to the carbon-oxygen double
bond of the benzoyl ester. Loss of benzoate results in formation of a carbon radical. A
second SET then forms the corresponding carbanion, which collapses and eliminates the
sulfone to form the trans alkene product.6

Scheme 1-2. Accepted Mechanism for SmI2 Mediated Julia Olefination

3

Recently our group has had an interest in investigating how substrate structure
could control the rate of the reductive elimination of a benzoyloxysulfone when treated
with samarium diiodide. We found that substrates with a phenyl group adjacent to either
leaving group (i.e. sulfone or benzoyl ester) readily yielded the elimination product.
However substrates with alkyl end groups as in compound 1.2 did not react. We also noted
that when the benzoylester is directly adjacent to the phenyl ring, the reaction proceeds in
only 30 minutes, whereas it takes 5 hours to go to completion when the sulfone is directly
adjacent to the phenyl ring (Scheme 1-3). 7

Scheme 1-3. Influence of Substrate Structure on SmI2/DMPU Reductive Elimination
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From these results, we concluded that the initial single electron transfer can occur
to either the sulfone or the benzoyl ester. This step is likely reversible, and it is the relative
stability of the subsequent carbon radical formed that determines which group is lost first
(Scheme 1-4). If the groups adjacent to the benzoyl and sulfone groups are equivalent, the
reaction will preferentially proceed through the initial SET to the benzoyl group. The
tendency for preferential SET to the benzoyl group can be explained by the reduction
potentials of each group. Phenyl sulfones have a reduction potential of about -2.30 V,8a
while a benzoyl group has a reduction potential of about -1.30 V,8b thus in general the
benzoyl group is more likely to be reduced than the sulfone.

Scheme 1-4. Formation of the Carbon Radical in a SmI2 Mediated Reductive
Elimination

We exploited this substrate control in the SmI2 mediated elimination of a bisacyloxysulfone 1.7. The reaction of 1.7 exhibited total chemoselectivity to produce diene
1.8, presumably proceeding through a resonance stabilized radical intermediate.9

5

Scheme 1-5. Influence of Substrate Structure on Chemoselectivity

For a similar investigation, another bis-benzoyloxysulfone, compound 1.10 was
prepared by double deprotonation of 1.9 with n-BuLi and addition to benzaldehyde
followed by bis-benzoylation of the two hydroxyls (Scheme 1-6).9 We anticipated that
treatment with SmI2 would result in formation of the allylic benzoate following selective
loss of the benzylic benzoyl ester to form a resonance stabilized carbon radical.
Unexpectedly, the fully eliminated non-conjugated alkene 1.12 was observed. Upon further
consideration this result was not entirely surprising. We proposed that after the first
reductive elimination occurred that generated the initially expected allylic benzoate 1.11,
a second SmI2 mediated reductive elimination would produce a resonance stabilized radical
intermediate, which would then proceed to the observed fully eliminated product. What
was not clear, however, was why this reaction selectively formed the non-conjugated fully
eliminated product as opposed to the conjugated product.

6

Scheme 1-6. Unexpected Results of the Selectivity Study

To test the intermediacy of the allylic benzoate, an analogous substrate was
synthesized by addition of n-BuLi to cinnamaldehyde, followed by trapping with benzoyl
chloride (Scheme 1-7). Treatment with SmI2 and DMPU gave the non-conjugated
elimination product in essentially the same ratio as the SmI2 mediated elimination of bisbenzoyloxysulfone 1.10. Placing the benzoyl group in the benzylic position as in
compound 1.17 and treatment with either SmI2 and H2O or SmI2 and DMPU gave
comparable results in both selectivity and yield (Scheme 1-8).9 The reaction was then
performed on the substrates with benzoyl groups in both positions and was treated with
SmI2 and D2O. Both reactions yielded the monodeuterated adduct, suggesting that both
substrates converge to the same organosamarium intermediate 1.23.

7

Scheme 1-7. Investigating the Intermediacy of the Allylic Benzoate

Scheme 1-8. Reductive Elimination of the Benzylic Positioned Benzoyl Group

Scheme 1-9. Deuterium Investigation of Organosamarium Intermediate

In order to try and explain the selectivity for the non-conjugated product, we looked
to previous report from Yoshida and coworkers.10 Their work suggested that selectivity can
be primarily attributed to sterics. They reported that reduction of an allylic phosphonate
1.24 with Pd(PPh3)4, SmI2 and H2O resulted in selectivity for the ɣ-isomer 1.25 via internal
delivery of a proton from the preferred pseudo-cyclic organosamarium intermediate 1.28.
Changing the proton source to tert-butanol gave the α-product 1.26 as the major isomer,
presumably proceeding through open protonation (Scheme 1-10).
8

Scheme 1-10. Comparable Work by Yoshida and Coworkers

By analogy, the results our group observed can be explained by steric preference
for the intermediate to exist as the organosamarium 1.28 following loss of the benzoyl
group. Internal protonation with H2O would then give the ɣ-isomer 1.25 (Scheme 1-10).
Our group then further illustrated that substrate structure could be manipulated to control
the ratio of conjugated to non-conjugated products. Reduction of tert-butyl substrate 1.30
using either DMPU or H2O gave little product selectively, due to minimal steric preference
for either organosamarium intermediate 1.33 or 1.34 (Scheme 1-11). The tri-methyl-benzyl
allylic benzoate 1.35 was prepared and treated with SmI2 and H2O. Selectivity for the ɣisomer 1.36 along with yield was increased when compared to the unsubstituted benzene
substrate, consistent with the proposed steric control over product selectivity (Scheme 112). 9
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Scheme 1-11. Controlling Regioselectivity with Sterics

Scheme 1-12. Further Investigation of Steric Influence over Selectivity

The remainder of this thesis details additional investigations aimed at better
understanding these types of samarium-mediated benzoyl ester elimination/isomerization
reactions. This will include some history on other samarium reduction reactions as well as
optimization and substrate-scope studies. The utility of our method is then showcased as a
key step in the total synthesis of a biologically important natural product honokiol. This
body of work paves the way for future applications of samarium-mediated benzoyl ester
reductions to access synthetically challenging important olefinic products.
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Chapter 2. Samarium Diiodide as a Reducing Reagent

2.1 Preparation Methods
Samarium diiodide was first reported as an electron transfer agent in 1977 by Henri
B. Kagan and coworkers,11 thus SmI2 is often referred to as “Kagan’s Reagent.” In the less
than 50 years since Kagan’s discovery, over 800 publications on the topic of samarium
diiodide have been produced.12 Samarium diiodide is now one of the most widely used
electron transfer agents in synthetic chemistry.
There are three published methods for preparing
SmI2. Kagan’s method involves reacting samarium metal
with diiodoethane at room temperature. The mechanism
likely involves an oxidative addition followed by betaelimination and loss of ethylene.8 Imamoto’s method, which
is the method we have utilized for our work, combines
samarium metal (Sm0) with iodine (I2) and the mixture is
refluxed overnight.13 The third method is Concellon’s

Figure 2-1. A Freshly
Prepared Solution of SmI2

method of preparation, which consists of combining
samarium metal with an oxidant, typically iodoform, and sonicating for about 15 minutes
to produce activated samarium diiodide.14 The activated solution of Sm II is a deep jade
blue (Figure 2-1) that becomes yellow when it is oxidized to Sm III. Because of this,
completion of reactions with SmI2 can be observed via color change.
SmI2 is prepared in a relatively safe manner and the reagent itself is fairly nontoxic, which was an important consideration for our lab. For example, the classical Julia
olefination utilizes a Na/Hg to reductively eliminate a β-acyloxysulfones to the
11

corresponding alkene, however SmI2 can be used a less toxic substitute (See Scheme 11).4,12 Comparatively, preparing a Na/Hg amalgam can be dangerous, as sodium metal is
highly reactive. The ease in preparation and the mild nature of SmI2 makes it more
attractive for synthetic applications. The remainder of this section details various recent
applications of SmI2 in synthesis, chosen to highlight the versatility and selectivity of this
reagent.

2.2 Exploring the Scope of Samarium Diiodide Mediated Reactions

In 2007 Py and Greene reported using SmI2 in a key diastereoselective step towards
the synthesis of several γ-amino acid derivatives (Scheme 2-1). Various nitrones were
reductively coupled with ethyl acrylate in order to produce the equivalent enantiopure (dr
>95:5) amino acid derivative in relatively high yields (71-94%). The more hindered
nitrones, with phenyl and tert-butyl groups adjacent to the nitrogen-carbon double bond,
were reduced to the corresponding hydroxyl amines instead of proceeding through the
reductive coupling, presumably due to steric hindrance. The group also utilized water as
an additive in order to decrease reaction times.15

12

Scheme 2-1. Diastereoselective Reductive Coupling by Py and Greene.

This decrease in reaction time in the presence of water can be attributed to the
coordination of the water to SmI2 thus enhancing the reduction potential of samarium. In
2010, the Flowers group reported using UV-Vis to determine that water displaces the
iodides from the inner coordination sphere of the samarium complex.16 They also reported
that even at very high molar equivalents (e.g. 500 equiv), water did not completely saturate
coordination sphere of samarium, as coordinative saturation would presumably deplete the
reductive capabilities of the metal.16 Extensive studies with SmI2-HMPA systems have
shown that HMPA behaves in a similar manner, and that this kind of metal-additive
complex produces open coordination sites on samarium so that it can bind to the substrate
being reduced.12, 16, 17, 18
In 1999 Keck and coworkers reported utilizing a SmI2-H2O system to
diastereoselectively reduce β-hydroxy ketones to 1,3-antidiols. The concentration of water
used dramatically effected the stereoselectivity of the diol products. They determined that
higher concentrations of water effectively competed with the substrate binding to
samarium, thus resulting in loss of selectivity (Scheme 2-2). 19
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Scheme 2-2. Diastereoselective Reductions of β-hydroxy Ketones to 1,3-antidiols by
Keck and Coworkers

In 2009, Hilmersson and coworkers showed that different protic co-solvents
produced different chemoselectivities. By utilizing a SmI2-H2O system with pyrolidine as
an additive they were able to run a chemoselective deprotection of a tosylate group in the
presence of an acetal group (Scheme 2-3), as well as halides, ketals, benzylic heteroatoms,
alkenes and other protecting groups such as tert-butyloxycarbonyl (Boc).

Scheme 2-3. Tosylate Deprotection by Hilmersson and Coworkers

The Otaka group also ran a chemoselectivity study on the reduction of a difluorobutenoate to test the effect of the protic co-solvents of the chemoselectivity (Scheme 24).21 The group found that use of tert-butanol resulted in selective reductive elimination of
a single fluorine. When ethanol was utilized instead of tert-butanol, they reported that the
chemoselectivity decreased and some alkene reduction had also occurred. The group

14

proposed that regardless of the proton source, the first mechanistic step of these reductions
was two single electron transfers to the carbonyl of the ester to form first a carbon radical
and then a carbanion (Scheme 2-5). They suggested that in the presence of tert-butanol,
the next step would be loss of one fluorine to form a samarium enolate intermediate. This
would be followed by protonation to selectively yield the mono-fluoro-butenoate product.
Conversely, when a SmI2-ethanol system is used, there are two suggested mechanistic
pathways. The first proposed mechanism is analogous to the reaction mechanism proposed
for the use of tert-butanol, and would result in the same reductive elimination of a single
fluorine group. The second proposed mechanism follows the formation of the carbanion
with two sequential protonation steps, and the resulting product would be the difluorobutanoate. The group suggested this loss of chemoselectivity may be due the greater steric
hindrance of tert-butanol as a proton donor.21

Scheme 2-4. Study of Proton Donor Effects of Chemoselectivty by Otaka et al

15

Scheme 2-5. Mechanistic Implications Observed by Otaka et al.

As mentioned in chapter one, the O’Neil group has previously worked with SmI2
in investigating control over selectivity of benzoyloxysulfones (see Scheme 1-5). Prior to
my Master’s Thesis work, the group had been employing a variable temperature scheme
when attempting SmI2-mediated elimination/isomerization reactions of allylic benzoates.
Specifically, the solution of SmI2 and any co-solvents was cooled to -78 °C, then warmed
to 0 °C for 10 minutes, then back -78 °C again, all prior to adding the elimination substrate.
The idea was that this allowed for pre-coordination of the additive to for the reactive
samarium complex.7,9 Results from these reactions were generally good, but the process
was cumbersome. In an attempt to improve the utility of the reaction, one of my first goals
was to simplify this set up. For instance could we simply perform the reaction by adding
the co-solvents/additives and substrate to SmI2 all at room temperature?
This simplified experimental set up was utilized for several SmI2-mediated
eliminations on both compounds 2.1 and 2.2. Importantly, yields and selectivities for these
room temperature reactions proved similar or even better than those conducted at lower
16

temperature. Results of these experiments are shown in Table 2-1. The regioselectivities
(i.e. conjugated vs. non-conjugated alkene products) for both compounds 2.1 and 2.2 were
the same, suggesting that both converge to the same organosamarium intermediate. The
results are also consistent with the idea that bulkier sterically hindered proton sources favor
the conjugated α-isomer. As mentioned in Chapter 1, this is likely due to preference for
open protonation due to steric hindrance of the preferred formation of a bound proton
source (see Scheme 1-10).10,12 Interestingly, additives such trimethylamine also give the
conjugated alkene product. We suggest that triethylamine may compete with water for
samarium coordination thus disrupting the internal protonation mechanism and giving
preference for the α-isomer. Smaller proton sources such as water and methanol both gave
selectivity for the ɣ-isomer. This is consistent with the proposal that less sterically hindered
proton sources can coordinate to samarium and protonation occurs internally via a
water/methanol-samarium complex.

Table 2-1. Investigation on Reaction Conditions and the Influence on Selectivity on
Compounds Type X

Entry
1
2
3
4
5
6

Conditionsa
H2O (200 eq.)
tBuOH (200 eq.)
MeOH (200 eq.)
MeOH (72 eq.), Et3N (72 eq.)
MeOH (72 eq.), MeNH2 (72 eq.)
Dimethylethylamine (200 eq.)

Ratio (ɣ:α)b
56:44 to 70:30
27:73 to 0:100
100:00
30:70 to 0:100
31:69
48:52

Yield (%)
75-85
21-76
90-100
90-100
100
71

Notes for Table: a) Reactions were performed with freshly prepared SmI2 (7 equiv.) in degassed THF at
room temp. for 24 h. b) Determined by 1H NMR.
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The results from the SmI2-mediated eliminations with methanol in particular were
noteworthy because it consistently exhibited total selectivity for the non-conjugated
terminal alkene product in very high yields. Although typically we had used a procedure
that allowed us to leave these reactions overnight, an NMR-based kinetic investigation of
SmI2-MeOH reductive eliminations showed that the reactions were complete within 5
minutes. Because of the various attractive aspects of the SmI2-MeOH experimental set up,
we continued to further explore its potential uses.
Thus far, our samarium mediated allylic benzoate elimination/isomerizations had
been conducted on substrates of type X (Figure 2-2), with a disubstituted trans-alkene or
a terminal alkene. We were interested in investigating the outcome of this reaction
performed on trisubstituted alkene-containing compounds of type Y (Figure 2-2). In
addition to further exploring the impact of substrate structure on the selectivity of this
reaction of the conjugated vs. non-conjugated compounds, the product from these reactions
would also contain a newly formed stereocenter. It was thought that these experiments
might

therefore

provide

the

basis

for

future

enantioselective

samarium

elimination/isomerization reactions. To test this, we began by preparing a series of
appropriate trisubstituted-alkene allylic-benzoate esters. Nine (9) differentially substituted
acetophenones (Figure 2-3) were subjected to a Horner Wadsworth Emmons reaction with
trimethyl phosphonoacetate to produce tri-substituted alkene methyl esters. Selectivities
from these reactions were generally 77:23 E/Z. All products were purified by column
chromatography, and in some cases it was possible to separate the isomers, giving some
mixed fractions and others of the pure E-isomer. All purified products were then reduced
with DIBAL-H to form the corresponding allylic alcohols. The allylic alcohols were
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purified by column chromatography, again being able to achieve some E/Z separation. The
purest fractions were then benzoylated and purified via column chromatography one last
time to give the desired starting materials of type Y for the SmI2-mediated elimination
study (Table 2-2).

Figure. 2-2. Substrates Type X and Y

Figure. 2-3. The Scope of 9 Aryl Substituted Acetophenones used as Starting
Materials for the Series of Reactions in Table 2-2
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Table 2-2. The Synthesis and Subsequent Reductive Elimination of 9 Tri-substituted
Alkene Compounds

Starting Material
Entry

1
2
3
4
5
6
7
8
9

# (substitution)
2.5 (o-Me)
2.6 (m-Me)
2.7 (p-Me)
2.8 (o-Cl)
2.9 (m-Cl)
2.10 (p-Cl)
2.11 (o-OMe)
2.12 (m-OMe)
2.13 (p-OMe)

Yield (%)
A
95.3
90.3
90
88.8
78.9
80.9
89.5
99.7
94.7

B
59.5
97.7
74.5
46.2
94.5
68.4
88.8
68.5
68.6

C
75.7
23.4
3.3
24.8
53.4
13.5
99.8
64.6
7.1

Isomers in
starting material
D
E only
E only
E only
E+Z
E only
E+Z
Z only
E+Z
E only

Relative Ratio of ɣ:α in
products
D
70:30
62:38
61:39
60:40
74:36
75:25
49:51
72:28
63:37

With the trisubstituted alkene allylic benzoates in hand, we could then examine
their reactions with SmI2. The results from these reactions are summarized in Table 2-2.
There are a few conclusions to be made from the results of these reactions. First, for all
compounds except 2.11, these reactions showed selectivity for the non-conjugated ɣ
product. This could potentially be explained by the fact that 2.11 was the only reactant that
was purified to only the cis-isomer for reaction D. This total loss of selectivity could have
occurred due to steric hindrance of proton delivery via a pseudo-cyclic organosamarium
intermediate (Figure 2-4).

20

Figure 2-4. Potential Steric Hindrance of Organosamarium Intermediate

It should also be noted that the results in Table 2-2 show that these SmI2-MeOH
mediated eliminations run on tri-substituted alkene starting materials were less selective
than the SmI2-MeOH mediated eliminations run on di-substituted compounds 2.1 and 2.2.
These results may suggest that the addition of a methyl group to the alkene disrupts (e.g.
slows down) internal proton delivery from a samarium-bound methanol. External
protonation then competes giving rise to higher amounts of the conjugated product.
The starting materials for reaction D of Table 2-2 can be thought of as analogous
to compound 2.2 (Figure 2-3). A complete set of data for these experiments would also
include compounds that were analogous to 2.1 as well. We proposed that this could be
achieved by through two synthetic steps. We anticipated that we could first utilize a
Grignard addition of vinyl magnesium chloride to compounds 2.5-2.13, then benzoylate
the resulting alcohols with benzoyl chloride (Scheme 2-6). The Grignard addition was
completed successfully on compound 2.10. However, the second benzoylation step was
unsuccessful. Even after several group members attempted what seemed like a simple
acylation, no formation of the desired product was observed. Instead, the attempted
benzoylation either yielded starting material or decomposition. We proposed that the lack
of success in formation of these starting materials was likely due to steric hindrance of the
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intermediate tertiary alcohol and the acidic prone elimination of the intermediate. The
synthesis of these compounds were not further investigated.

Scheme 2-6. Proposed Synthesis of Second set of Starting Materials for Selectivity
Study.

To expand the study, we also prepared compound 2.17, which began with the
reaction of ethynylbenzene and hexanal to produce alcohol 2.16. Treatment with benzoyl
chloride and pyridine then gave elimination/isomerization substrate 2.17. When 2.17 was
treated with SmI2 and MeOH, both eliminated products 2.18 and 2.19 were observed by
1

H NMR. This reaction resulted in a higher selectivity for the non-conjugated ɣ product

than the reactions of Table 2-2, and more in line with the selectivities of the SmI2-MeOH
eliminations of disubstituted alkene compounds 2.1 and 2.2. This result again demonstrates
how substrate structure can influence selectivities from these reactions.

Scheme 2-7. Further Investigation of the SmI2-MeOH System
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Chapter 3. Total Synthesis of Honokiol
3.1 Biological Importance and Isolation of Honokiol
Honokiol was first identified as a component of Magnolia obovata, a magnolia tree
native to Japan, in 1973 by M. Fujita and coworkers.22 Honokiol occurs naturally in the
bark of trees in the genus Magnolia (Figure 31) with a mixture of similar biphenolic natural
products,

including

its

structural

isomer

magnolol (Figure 3-2). For centuries the bark of
these trees have been ground into a powder and
used throughout Asia as herbal supplements.
Some of these traditional herbal remedies are
hou po and saiboku-tu.23 Although honokiol has
long been a component of ancient healing
methods, it was not until Fujita’s isolation of the
Figure 3-1. Magnolia × soulangeana
growing in Bellingham, Washington

compound that significant interest in the
biofunctionalities of honokiol began to rise. By

the 1990’s honokiol specific biological benefits had been further elucidated.24-26 For
instance, it was shown that honokiol prevents the formation of blood clots through
inhibition of thromboxane formation. 24

23

Figure 3-2. Structure of Honokiol and Magnolol

Honokiol was also determined to be an effective antioxidant through peroxy radical
scavenging,24, 26 although these studies generally relied on qualitative, indirect analysis of
the radicals themselves meaning that the exact mechanism by which honokiol exerts its
antioxidant activity was not known. In 2015 Amorati and coworkers used an autoxidation
method to quantitatively determine the antioxidant activity of honokiol, as well as that of
magnolol. The experiment involved using azobis(isobutyronitrile) as an initiator to produce
peroxy radicals. In the presence of a good antioxidant, the rate of oxygen consumption by
this initiator would be slower than if that antioxidant was not present in the reaction system.
By measuring the rate of oxygen uptake, the group was able to determine a rate constant
(k of Scheme 3-1) for the reaction of peroxy radicals that are responsible for the majority
of harmful oxidative chain propagation events in nature and man-made materials. The
group found that honokiol’s antioxidant activity was approximated double that of
magnolol. They suggested that this was due to the two ortho hydroxyl groups of magnolol
forming a strong hydrogen bond between one another. Tied up in this fashion they are less
reactive toward peroxy radicals which significantly decreases the antioxidant activity of
the compound. 26
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Scheme 3-1. Mechanism of Radical Scavenging by an Antioxidant (AH).

Another biological benefit of honokiol is its anti-inflammatory properties. NF-ĸB
proteins are known pro-inflammatory activators, as well as being known to be responsible
for enhancing transcription of HIV. Honokiol has been found to inhibit NF-ĸB protein
activation through several pathways: inhibiting TNF induced activation, IĸBα
phosphorylation and degradation, and RANKL-mediated activation. It has also been found
that honokiol is both capable of crossing the blood brain barrier and has low cytotoxicity
towards non-target cells.23, 27 While these are all very attractive qualities for implementing
clinical use, perhaps one of the biggest reasons for the interest in honokiol, is its antitumor
properties.
The antitumor activity of honokiol proceeds through two primary pathways, both
involving the p53 protein. The p53 protein is sometimes referred to as “the guardian of the
genome.” It is comprised of 393 amino acids that make up four functional domains: a
domain that activates transcription factors, and domain responsible for regulating
tetramerization, a domain that recognizes specific DNA sequences, and a domain that
recognizes damaged DNA. It has 3 primary functions that are responsible for the regulation
of the cell cycle, and therefore it functions as a tumor suppressant. The first function of the
p53 is to target genes that regulate growth arrest of cells with mutations or damaged DNA.
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The second function is to initiate DNA repair, and the third function is initiation of
apoptosis, which is considered a “last resort defense” against tumor growth.28, 29
Extensive amounts of research on many types of cancer has shown that the p53
protein has a significant role in tumor growth. While healthy tissues have cells with low
levels of the p53 protein, DNA damage and stress signals typically trigger an increase in
p53 levels. It has been determined that over 50% of all tumors contain mutant p53 proteins.
A mutant p53 protein may be incapable of cell regulation processes that prevent damaged
and mutant DNA from proliferating to form tumors. In other tumors with wild-type p53
proteins, it is typically the case that the wild type p53 is being inactivated or deregulated
by a DNA tumor virus. 28
Studies have shown that honokiol directly targets these p53 mutants that are
common in most tumors. It is not well understand exactly which mechanisms allow
honokiol to be so effective for the treatment of cancer, but the general anti-cancer pathways
that honokiol takes have been the subject of several studies, and there is a general
understanding that honokiol is capable of targeting tumors in at least two ways. For tumors
with mutant p53, honokiol has been found to promote cell cycle arrest and apoptosis,
providing the necessary “kill switch” on tumor growth that mutant p53s lack. For wild type
p53, it has been suggested that honokiol’s antioxidant properties prevents reactive oxygen
species from promoting tumor growth. 28
Isolation of naturally occurring honokiol is possible, but it requires extensive
processing, resulting in high costs to achieve pharmaceutical grade purity. On average,
there is about 9 mg – 100 mg of honokiol for every 10 grams of tree bark (0.1 – 1.0% w/w),
depending on the age of the tree. Trees around 2 years old will only contain 9 mg of
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honokiol. It is not until that tree is 20 years old that every 10 grams of bark will contain on
average 100 mg of honokiol.22
One isolation method reported by Liu and coworkers in 2010 described the use of
preparative HPLC as a “facile, fast and economical” method for purifying honokiol from
an extract of Magnolia officinalis.30 However, when looking into the details of this
methodology, there are many preparative steps involved. First, a crude extract is produced
through several hours of ethanol reflux on about a 200 gram sample of powdered magnolia
officinalis (A 200 gram sample of 2 year old bark would contain about 180 mg of honokiol,
while a 200 gram sample of 20 year old bark would contain about 2 grams of honokiol).
The extract of main compounds (i.e. honokiol, magnolol, and 4-methoxyhonokiol) had to
be purified from the crude extract by drying, filtering, and pH adjustments. From there the
samples can only be loaded in portions of about 70 mg of the biphenolic mixture of main
compounds at a time, with a run time of 40 minutes each in order to achieve a purity of
>98% (but still less than 99% purity). One run of their optimized HPLC procedure
produced on average about 10 mg of 98.1% purity honokiol.30 That means for a sample of
young bark (assuming 2 years of tree growth), after preparation of the extract it would then
take 120 hours of preparative HPLC in order to recover the 1.8 grams of naturally produced
honokiol. For a sample of older bark (~1.0 % w/w honokiol), approximately 148 hours
(just over 6 full days) of preparative HPLC would be required in order to recover the 2
grams of naturally produced honokiol. This of course does not take into account the time
associated with harvesting, drying, processing, and extracting the biomass. Nor does it
include the 20 years of growing time required for the tree to mature.
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Another method for extracting and purifying honokiol from the natural source
involves reacting the extracted mixture of magnolol and honokiol with dimethyoxypropane
in order to selectively protect magnolol (Scheme 3-2).31The mixture can then be separated
by column chromatography on silica. While this method avoids the time-delay associated
with HPLC (silica chromatography can accommodate larger masses of material), the
overall yields from the magnolia tree is the same.

Scheme 3-2. Protection of Magnolol in Order to Achieve Separation by column
Chromatography

3.2 Previous Syntheses of Honokiol

The synthesis of honokiol is an area of great interest due to the difficulty of isolating
sufficient quantities of the natural product combined with its therapeutic potential. In 2009
the Chen group developed a five step method for synthesizing honokiol in 32% overall
yield (Scheme 3-3).32 Bromination of 1-allyl-4-methoxy benzene resulted in a 68% yield
of the desired bromobenzene product C2. A Suzuki coupling with boronic acid C3 was
then utilized for the formation of the biaryl C-C bond. Notably, the Chen group found that
typical Suzuki conditions (PdCl2 and K3PO4 in toluene, Pd(OAc)2–dppf and K2CO3,
Pd2(dba)3–P(t-Bu)3 and Cs2CO3 in 1,4-dioxane, Pd2(dba)3–PCy3 and K3PO4 in 1,4-
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dioxane–H2O) resulted in only trace product formation. After investigating 14 different
experimental conditions, the catalytic system of Pd2(dba)3 along with the ligand 2dicyclohexylphosphino-2’,6’-dimethoxybiphenyl successfully yielded the desired biaryl
product C4 in 83% yield. Allylation of the hydroxyl group with allyl bromide gave the
target allyl ether C5 in 90% yield. A Claisen rearrangement catalyzed by boron trichloride
followed by demethylation with boron tribromide provided honokiol in a 64% yield after
column chromatography. The overall yield for this sequence was 32% from C1. 32
Scheme 3-3. Chen’s 2009 Synthesis of Honokiol

In 2010 Denton and coworkers devised a five step total synthesis of honokiol.33
Similar to Chen, their synthesis featured a Suzuki coupling followed by an aromatic
Claisen rearragnement. The first step was directed ortho-lithiation of compound D1 to
produce allylic boronate ester D2 in 77% yield (Scheme 3-4). For the following cross
coupling step, they tried a large variety of conditions and found that the allyl group was
frustratingly sensitive to most conditions. The previously optimized Suzuki coupling
29

conditions by Chen were necessary in order to successfully synthesize D3, the biaryl core
of honokiol, in 94% yield. Subsequent allylation of Suzuki coupling product D3 with allyl
bromide yielded the desired allyl ether D4 in 99% yield. The Denton group then utilized
microwave irradiation for a thermally initiated Claisen rearrangement to produce
compound D5 in 86% yield. Demethylation was completed in 91% yield with BCl3SMe2
to give honokiol in 55% overall yield.33

Scheme 3-4. Denton’s 2010 Synthesis of Honokiol

Most recently, in 2014 Srinivas reported to date the highest yielding synthesis of
honokiol (Scheme 3-5) to date at 68% overall yield.34 First they converted 2-bromoanisole
to the corresponding organomagnesium intermediate with magnesium turnings and
catalytic iodine. A Kumada coupling with 4-iodoanisole catalyzed by Pd(PPh3)4 yielded
biaryl core S2 in 85% yield. Directed bromination in the presence of acetic acid and
hydrogen peroxide gave S3 in 96% yield. This was then converted into another
organomagnesium intermediate for another Kumada cross coupling with allyl bromide,
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again catalyzed by Pd(PPh3)4, to give S4 in 86% yield. Demethylation of both methoxy
substituents was achieved in 97% yield with AlCl3 and DMS to produce honokiol in 68%
overall yield.34

Scheme 3-5. Srinivas’s 2014 Synthesis of Honokiol

3.3 The Total Synthesis of Honokiol
We also became interested in synthesizing honokiol, due to its biological
importance and also because the two benzene allyl substituents of honokiol could
potentially be synthesized by reductive elimination/isomerization of a benzoyl ester with
samarium diiodide. The result would be a convergent synthesis of honokiol that would
involve cross coupling of two nearly complete fragments of honokiol, and a final
demethylation step (Scheme 3-6).
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Scheme 3-6. Proposed Retrosynthesis of Honokiol

The commercial bromo methoxybenzaldehydes 3.4 and 3.7 were subjected to a onepot addition/benzoylation with vinyl magnesium bromide followed by trapping with
benzoyl chloride to produce compounds 3.3 and 3.6 in 92 and 90% yields, respectively
(Scheme 3-7). Reductive elimination of the benzoyl groups with SmI2 and MeOH resulted
in high selectivity (>9:1) for the non-conjugated terminal alkene products 3.2 and 3.5 in
high yields. These results are consistent with the selectivities observed for similar reductive
eliminations done by our group with SmI2 and MeOH on less complex substrates (See
Table 2-1). It is worth noting that the potentially labile bromide substituent is tolerated in
the reaction. Overall, fragments 3.2 and 3.5 were obtained fairly quickly in 83% overall
yield on multi-gram scale, suggesting that we were on the path towards a quick, high
yielding synthesis of honokiol.
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Scheme 3-7. Steps One and Two of Our Proposed Four Step Synthesis

For the cross-coupling of 3.2 and 3.5, we attempted many different conditions in
line with our proposed synthesis in Scheme 3-6. In addition to different catalysts,
additives, solvents, and temperatures, one can also envision two different coupling
scenarios: (1) conversion of 3.2 to a suitable organometallic followed by cross-coupling
with 3.5 or (2) conversion of 3.5 to a suitable organometallic followed by cross-coupling
with 3.2. Results from these experiments are summarized in Table 3-1. Ultimately, we
concluded that the sensitivity of the allyl groups combined with the steric hindrance from
the methoxy group of fragment 3.5 made this an incredibly challenging coupling to
optimize (vide infra).
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Table 3-1. Attempted Cross Coupling Conditions

Entry

Reagents

Catalyst

Solvent

1

Mg, I2

Pd(PPh3)4

THF

Pd(PPh3)4

THF

Pd(PPh3)4

THF

Pd-Peppsi-iPr

THF

Pd-Peppsi-iPr

THF

tBuLi, ZnBr2,
LiCl, NMP
tBuLi, ZnBr2,
LiCl, NMP
tBuLi, ZnBr2,
LiCl, NMP
tBuLi, ZnBr2,
LiCl, NMP

2
3
4
5
6

NaOt-Bu, D3

Pd(dba)2

toluene

7

tBuLi

Pd-Peppsi-iPr

toluene

Pd(PPh3)4

DMF

Pd(PPh3)4

DMF

Pd(PPh3)4

toluene

Pd(PPh3)4

THF

8
9
10
11

B2pin2, PdOAc,
KOAc, Cs2CO3
B2pin2, PdOAc,
NaOAc,
Cs2CO3
B2pin2, PdOAc,
NaOAc, K2CO3
B2pin2, PdOAc,
NaOAc, K2CO3

Temp, Time
-78°C, 4 hr,
RT, 8 hr
-78°C, 4 hr,
Reflux, 18 hr
-78°C, 4 hr,
RT 4 hr
-78°C, 4 hr,
RT, 2 hr
-78°C, 4 hr
RT, 8 hr
-78°C, 1 hr,
50°C, 5 hr
-78°C, 1 hr,
50°C, 5 hr
80°C, 18 hr
(x2)
80°C, 18 hr
(x2)
80°C, 18 hr
(x2)
80°C, 18 hr
(x2)

Yield (%)
0
0
trace
0
0
trace
0
10
trace
trace - 11
trace

Each entry in Table 3-1 was run with both 3.2 and 3.5 being first converted to an
organometallic reagent (see discussion above), and both routes gave yields that were
generally disappointing. Most reactions produced none of the coupled product or merely
trace amounts as detectable by MS. For instance, our attempted Kumada coupling gave
none of the desired product despite this reaction being reportedly successful by Srinivas on
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very similar substrates.34 Further attempts at a Negishi or Hiyama cross coupling method
were also unsuccessful. Most often the products we observed from these reactions seemed
to be products of polymerization, isomerization, or debromination. In order to investigate
if the allyl group was preventing the cross coupling reaction from proceeding, we treated
both starting materials 3.2 and 3.5 with both nBuLi and tBuLi (2 equiv, entries 2-5 and 7),
then quenched the reactions with D2O. This resulted in deuterium labelling at the allylic
position with minor amounts of deuterium labelling at the aryl bromine position. This
results is perhaps not surprising as the pKa of these protons in allylbenzene was reported
to be 34 (pKa of BuLi is ~50). This indicated that instead of the organolithium reagents
facilitating debromination and formation of the corresponding organometallic reagent for
cross-coupling, they were reacting with the allyl substituent. We also attempted several
organolithium-free cross couplings (entries 6, 8-11), but in all cases low yields
accompanied by some isomerization of the allylic alkenes to the more stable conjugated
internal alkene were observed. The results suggested that cross coupling with the nearly
complete fragments 3.2 and 3.5 was challenging due to the sensitivity of the terminal
alkenes. In their synthesis of honokiol, Chen also commented on the sensitivity of the allyl
groups. We therefore set out to investigate a new synthesis, one where the allyl groups
would be added to the biaryl core post-coupling (Scheme 3-8). Among the final steps
would then be a bis-benzoylester elimination/isomerization reaction.
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Scheme 3-8. New Proposed Route for Synthesis of Honokiol

Since the Suzuki conditions we had used for the previous synthetic route were the
most promising (entries 8 and 10), we began by investigating the Suzuki cross-coupling
between commercial aldehydes 3.4 and 3.7 (Table 3-2). The first step of these crosscouplings all involve formation of a boronate ester from an aryl bromide. We found that
regardless of what conditions were used, only compound 3.4 produced the corresponding
boronate ester (3-10 of Scheme 3-9) in quantitative yield. The lower yields (45%) from
bromo benzaldehyde 3.7 under the same conditions is likely due to the sterics caused by
the ortho-methoxy group. One of the attractive features of Suzukia-Miyaura reactions is
that boronate esters are generally stable and can be isolated/purified before being taken into
the cross-coupling (“two-pot” set up). Alternatively, couplings of this type can also be run
without isolation of the boronate ester, and performing the cross-coupling in situ (“onepot”). After some optimization, we determined that the best conditions for synthesis of
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cross-coupled product 3.9 was treatment of 3.4 with Pd(dppf)Cl2 and KOAc in p-dioxane
with bis-pinocaloto diboron at 90°C for 24 hours in order to form boronate ester 3.10. At
this point, the reaction can either be quenched with H2O, dried, and concentrated in vacuo
for analysis or storage to proceed through the two-pot method, or the reaction mixture can
simply be cooled to room temperature and kept under nitrogen to proceed through the onepot method. Boronate ester 3.10 is then utilized for cross coupling with 3.7 by treatment
with Pd(tBu3)2 in p-dioxane with Na2CO3 in H2O as the base. This optimized set up
produces 3.9 in quantitative yields.
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Table 3-2. The Conditions Explored for Optimization of Coupling Compound 3-4
with 3-7

Entry
1
2

3

4

5

6

7

8

9

Reagents
B2pin2, PdOAc,
KOAc, Cs2CO3
B2pin2,
Pd(dppf)Cl2,
KOAc, Cs2CO3
B2pin2,
Pd(dppf)Cl2,
KOAc, Cs2CO3
B2pin2,
Pd(dppf)Cl2,
KOAc, K2CO3
B2pin2,
Pd(dppf)Cl2,
KOAc, K2CO3
B2pin2,
Pd(dppf)Cl2,
KOAc, K2CO3
B2pin2,
Pd(dppf)Cl2,
KOAc, K2CO3
B2pin2,
Pd(dppf)Cl2,
KOAc, Na2CO3
in H2O
B2pin2,
Pd(dppf)Cl2,
KOAc, Na2CO3
in H2O

Coupling
Catalyst

Solvent

Pd(PPh3)4

DMF

Pd(PPh3)4

EtOH/toluene

80°C, 18 hr
(x2)

trace

Pd(PPh3)4

EtOH/toluene

90°C, 24 hr
(x2)

trace

Pd(PPh3)4

EtOH/toluene

90°C, 24 hr
(x2)

trace

Pd(PPh3)4

DMF

90°C, 24 hr
(x2)

16

Pd(PPh3)4

p-dioxane

90°C, 24 hr
(x2)

27

Pd(tBu3)2

p-dioxane

90°C, 24 hr
(x2)

64

Pd(tBu3)2

p-dioxane

90°C, 24 hr
(x2)

74 - 91

Pd(tBu3)2

p-dioxane

90°C 24 hr,
70°C 24 hr

100
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Temp, Time
80°C, 18 hr
(x2)

Isolated Yield
(%)
trace

Scheme 3-9. Optimized Cross Coupling Conditions

With biaryl compound 3.9 in hand, vinyl magnesium bromide was then added into
both aldehydes giving diol 3.11 in 71% yield after column chromatography. Benzoylation
of 3.11 produced 3.8 that was used directly without further purification.
Elimination/isomerization of both benzoyl esters with SmI2 and MeOH then gave 3.1 in
98% yield for the two steps.

Scheme 3-10. Addition and Benzoylation Steps of Total Synthesis

Scheme 3-11. Reductive Elimination of Benzoyl Esters
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The final demethylation step of our total synthesis of honokiol proved to be
somewhat challenging. This was first attempted using the procedure described by Srinivas
on the same compound with AlCl3 and DMS for which they reported obtaining honokiol
in 68% yield (Scheme 3-5).34 In our hands, their conditions resulted in decomposition of
3.1. Knowing that the allylic groups could potentially cause us the same issues we faced
during the cross coupling optimization, we looked to work from Vyvyan and coworkers to
try and find a mild demethylation that wouldn’t cause decomposition of our product
(Scheme 3-12).35 Their group had used catalytic amounts of BArF reagent with
triethylsilane to form a silyl ether intermediate in order to complete the last demethylation
step in their synthesis of heliannuol E. They then treated the silyl ether with TBAF to get
the desired demethylated alcohol. Heliannuol E, like honokiol, contains a terminal alkene,
so we were optimistic that these would be appropriately mild conditions for our synthesis.

Scheme 3-12. Demethylation to Produce Heliannuol E by Vyvyan and Coworkers

Our first attempted reaction using these conditions was successful, but use of the
solvent DMF made isolation of the product difficult. By switching to THF, we observed
successful demethylation and were able to purify honokiol by column chromatography in
an isolated 60% yield (Scheme 3-13). Once we had found demethylation conditions that
resulted in a relatively high overall yield of 41%, we attempted to scale up the synthesis of
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honokiol from the milligram scale we were working on to the gram scale. Each step was
completed successfully upon scale up, except for the demethylation. We believe the BArF
catalyst had decomposed after the first two reactions we utilized it for. We tested this by
running the reaction with catalyst loading up to 50%, and then ran a reaction with the BArF
present in a 1:1 ratio with 3.1, and both gave back 3.1 untouched. We also tried
recrystallizing the BArF in dry hexanes, but to no avail. A fresh commercially produced
bottle of BArF was purchased, and then stored in a glove box in order to prevent catalyst
decomposition. After taking the proper precautions to avoid atmospheric exposure to the
catalyst, we were able to repeat the demethylation step in consistent yields of about 60%.

Scheme 3-13. Optimized Deprotection Conditions

3.4 Conclusion

Inspired by the versatility of the uses of samarium diiodide and its application to
Julia-type reductive eliminations, we initially set out to determine how substrate structure
would influence rate of reaction. When the reductive elimination of a bis-
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benzoyloxysulfone selectivity produced a fully eliminated non-conjugated alkene product,
we began to investigate how various changes in substrate structure as well as reaction
conditions could affect the control over product selectivity. We found that reductive
eliminations that were mediated by samarium diiodide were capable of highly fine-tuned
selectivity of products based on sterics caused by substrate structure and the additives used.
The ability for our group to selectivity synthesize terminal non-conjugated alkene
substituents with a SmI2-MeOH reaction system inspired us to use these optimized
conditions in order to complete the total synthesis of a natural product. We chose honokiol
due to its highly desirable oncological properties that have inspired many biological studies
in recent years.
We were frustrated to find that our initially proposed pathway for completing the
synthesis of honokiol was repetitively unsuccessful at the second to last step due to the
sensitivity of the allylic groups. However, after adjusting our synthetic route, we were able
to complete the synthesis of honokiol in 41% overall yield.
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Chapter 4. Experimentals

All reactions were carried out under N2, in flame-dried glassware. The solvents
used were dried via passing the solvent through a column of activated alumina under N2
immediately prior to use. All other reagents were purchased and used as received. All TLC
analysis used 0.25 mm silica layer fluorescence UV254 plates. NMR: Spectra were
recorded on a Varian Mercury 300, or Inova 500 spectrometer in the solvents indicated;
chemical shifts (δ) are given in ppm, coupling constants (J) in Hz. The solvent signals were
used as references (CDCl3: δC = 77.0 ppm; residual CHCl3 in CDCl3: δH = 7.26 ppm).

SmI2 (0.1 M in THF) Dry THF (250 ml) was further degassed by freeze, pump, thaw
twice. To the degassed THF was added Samarium metal (3.76g, 25.0 mmol, 1 equiv) before
adding I2 (3.29g, 13.0 mmol, 0.52 equiv). The mixture was stirred at 60°C overnight and
then cooled to room temperature to give a deep blue solution of SmI2 (0.1 M).

1-phenylallyl benzoate (2.1). One step method: To a schlenk tube of benzaldehyde (2.04
ml, 20 mmol, 1.0 equiv) in THF (10 ml) was added vinyl magnesium bromide (13.7 ml, 26
mmol, 1.3 equiv) at 0°C. The reaction mixture was stirred for one hour before adding
benzoyl chloride (4.05 ml, 30 mmol, 1.5 equiv) and then stirring at 0°C overnight. The
reaction mixture was quenched with aqueous NH4Cl (25 ml) and extracted with MTBE (2
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x 25 ml). The organic extracts were dried over MgSO4 and concentrated in vacuo.
Purification by column chromatography on silica (4:1 hexanes:ethyl acetate) gave
compound 2.1 (4.73 g, 99% yield) as a pale yellow oil.

Two step method: To a schlenk tube of benzaldehyde (1.02 ml, 10 mmol, 1.0 equiv) in THF
(10 ml) was added vinyl magnesium bromide (18.6 ml, 13 mmol, 1.3 equiv) at 0°C. The
reaction mixture was stirred for one hour before quenching with aqueous NH4Cl (25 ml)
and extracted with MTBE (2 x 25 ml). The organic extracts were dried over MgSO4 and
concentrated in vacuo. The crude reaction mixture was transferred to a schlenk tube with
DCM (35 ml). Pyridine was added to the mixture at 0°C before the addition of benzoyl
chloride (0.51 ml, 4.35 mmol, 1.5 equiv). The reaction mixture was then let warm to room
temperature while stirring overnight. The reaction was quenched with aqueous NaHCO3
(50 ml) and extracted with MTBE (2 x 50 ml). The organic extracts were dried over MgSO4
and concentrated in vacuo. Purification by column chromatography on silica (4:1
hexanes:ethyl acetate) gave compound 2.1 (3.04 g, quantitative yield) as a pale yellow oil.
1

H NMR (500 MHz, Chloroform-d) δ 8.17 – 8.06 (m, 2H), 7.62 – 7.53 (m, 3H), 7.52 – 7.29

(m, 5H), 6.56 (dd, J = 5.8, 1.5 Hz, 1H), 6.16 (ddd, J = 17.2, 10.5, 5.8 Hz, 1H), 5.43 (dt, J
= 17.1, 1.4 Hz, 1H), 5.40 (s, 2H), 5.33 (dt, J = 10.5, 1.3 Hz, 1H).

cinnamyl benzoate (2.2) To a schlenk tube of the commercially available cinnamyl
alcohol (1.29 ml, 10 mmol, 1.0 equiv) in DCM (50 ml) was added pyridine (1.61 ml, 20
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mmol, 2.0 equiv) at 0°C before adding benzoyl chloride (1.39 ml, 12 mmol, 1.2 equiv).
The reaction mixture was let warm to room temperature as it stirred overnight. The reaction
was quenched with aqueous NHCl4 (50 ml) and extracted with EtOAc (2 x 50 ml). The
organic extracts were dried over MgSO4 and concentrated in vacuo. Purification by column
chromatography on silica (4:1 hexanes:ethyl acetate) gave compound 2.2 (4.56 g, 96%
yield) as a pale yellow oil.
1

H NMR (300 MHz, Chloroform-d) δ 8.63 – 8.54 (m, 1H), 8.24 – 7.98 (m, 3H), 7.67 – 7.53

(m, 1H), 7.57 – 7.14 (m, 3H), 6.70 (dd, J = 15.9, 1.6 Hz, 1H), 6.35 (dt, J = 15, 6 Hz, 1H),
4.95 (dd, J = 6.4, 1.4 Hz, 2H).

General procedure SmI2-mediated reductive eliminations: To a schlenk tube of SmI2 (70
ml, 7.0 mmol, 7 equiv) was added MeOH (8.1 ml, 200 mmol, 200 equiv) before adding
either cinnamyl benzoate or 1-phenylallyl benzoate (0.24 g, 1.0 mmol, 1.0 equiv) to the
reaction flask before stirring at room temperature overnight. The reaction was quenched
with aqueous NaHCO3 (50 ml) and extracted with EtOAc (2 x 50 ml). The organic extracts
were dried over MgSO4 and concentrated in vacuo. Purification by column
chromatography on silica (4:1 hexanes:ethyl acetate) gave a mixture of compounds 2.3 and
2.4 (0.107 g, 91% yield) as a pale yellow oil.
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Spectral data for 2.3: 1H NMR (300 MHz, Chloroform-d) δ 8.14 – 8.01 (m, 1H), 7.62 –
7.41 (m, 1H), 7.48 – 7.33 (m, 1H), 7.39 – 7.12 (m, 3H), 6.09 – 5.89 (ddt, J = 20, 10, 5 Hz,
1H), 5.17 – 5.03 (m, 2H), 3.93 (d, J = 0.6 Hz, 1H), 3.81 – 3.64 (m, 1H), 3.40 (d, 2H).

Spectral data for 2.4: 1H NMR (300 MHz, Chloroform-d) δ 7.65 – 7.09 (m, 5H), 6.54 –
6.34 (d, J = 6 Hz, 1H), 6.13 (dq, J = 6, 0.2 Hz, 1H), 2.04 (d, J = 0.4 Hz, 3H).

methyl 3-phenylbut-2-enoates General procedure for Horner-Wadsworth Emmons
Reaction on compounds 2.5-2.13 of Table 2-2: To a schlenk tube of NaH (0.196g, 8.2
mmol, 1.1 equiv) in THF (8.2 ml) was added TMPA (1.33 ml, 8.2 mmol, 1.1 equiv)
dropwise over 5 minutes. The reaction was stirred at 0°C for 30 minutes before the slow
addition of a solution of acetophenone (7.45 mmol, 1.0 equiv) dissolved in THF (2.0 ml)
to the reaction flask. The reaction was then refluxed at 70°C for 18 hours. The reaction was
quenched with H2O (15 ml) and extracted with EtOAc (3 x 15 ml). The organic extracts
were dried over MgSO4 and concentrated in vacuo. Purification by column
chromatography on silica (4:1 hexanes:ethyl acetate) gave the corresponding methyl
phenylbutenoates as a mixture of E/Z isomers (1.27 g – 1.55 g, 93-99% yield) as a colorless
oil.
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Spectral data for mixtures of E and Z isomers:
methyl 3-(o-tolyl)but-2-enoate 1H NMR (500 MHz, Chloroform-d) δ 7.71 (dd, J = 7.6, 1.4
Hz, 2H), 7.38 (td, J = 7.5, 1.4 Hz, 2H), 7.08 (dd, J = 7.6, 1.6 Hz, 2H), 7.01 – 6.94 (m, 2H),
6.00 (dqd, J = 7.6, 1.5, 0.5 Hz, 1H E), 5.82 – 5.76 (m, 1H Z), 3.76 (d, J = 0.5 Hz, 3H E),
3.54 (d, J = 0.6 Hz, 3H Z), 2.62 – 2.49 (m, 6H E, Z), 2.47 (td, J = 1.5, 0.5 Hz, 3H E), 2.30
(d, J = 1.9 Hz, 3H Z).
methyl 3-(m-tolyl)but-2-enoate 1H NMR (500 MHz, Chloroform-d) δ 7.38 (td, J = 7.5, 1.4
Hz, 2H), 7.30 – 7.20 (m, 2H), 7.19 – 7.13 (m, 2H), 7.11 – 7.04 (m, 2H), 5.98 (dq, J = 8.6,
1.5 Hz, 1H E), 5.77 (dq, J = 6.1, 1.5 Hz, 1H Z), 3.76 (d, J = 2.6 Hz, 6H), 3.53 (s, 3H), 3.39
(d, J = 9.1 Hz, 3H), 2.59 (s, 3H), 2.54 (s, 3H).
methyl 3-(p-tolyl)but-2-enoate 1H NMR (500 MHz, Chloroform-d) δ 7.79 – 7.71 (m, 2H),
7.40 – 7.29 (m, 2H), 7.19 – 7.13 (m, 2H), 7.03 – 6.96 (m, 2H), 6.13 (t, J = 1.3 Hz, 1H E),
5.89 (t, J = 1.5 Hz, 1H Z), 3.74 (s, 3H), 3.55 (s, 3H), 2.62 – 2.54 (m, 6H), 2.42 – 2.34 (m,
6H).
methyl 3-(2-chlorophenyl)but-2-enoate 1H NMR (500 MHz, Chloroform-d) δ 7.86 (d, J =
8.2 Hz, 2H), 7.41 – 7.34 (m, 2H), 7.20 – 7.09 (m, 4H), 6.14 (q, J = 1.3 Hz, 1H E), 5.90 (q,
J = 1.5 Hz, 1H Z), 3.74 (s, 3H), 3.57 (s, 3H), 2.60 – 2.54 (m, 3H), 2.38 (d, J = 19.8 Hz,
3H).
methyl 3-(3-chlorophenyl)but-2-enoate1H NMR (500 MHz, Chloroform-d) δ 7.43 – 7.34
(m, 3H), 7.25 – 7.11 (m, 3H), 7.10 – 7.04 (m, 2H), 6.02 (q, J = 1.5 Hz, 1H E), 5.84 (q, J =
1.4 Hz, 1H Z), 3.75 (d, J = 0.8 Hz, 3H), 3.54 (d, J = 0.8 Hz, 3H) 2.49 (d, J = 1.4 Hz, 7H).
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methyl 3-(4-chlorophenyl)but-2-enoate1H NMR (500 MHz, Chloroform-d) δ 7.91 – 7.85
(m, 2H), 7.37 – 7.24 (m, 4H), 7.17 – 7.10 (m, 2H), 6.10 (t, J = 1.3 Hz, 1H E), 5.92 (q, J =
1.5 Hz, 1H Z), 3.74 (s, 3H), 3.56 (s, 3H), 2.60 – 2.50 (m, 6H).
methyl 3-(2-methoxyphenyl)but-2-enoate 1H NMR (500 MHz, Chloroform-d) δ 7.78 –
7.69 (m, 1H), 7.11 (ddd, J = 7.5, 1.8, 1.0 Hz, 1H), 7.04 – 6.85 (m, 6H), 5.95 (p, J = 1.3 Hz,
1H E), 5.90 (dd, J = 1.8, 0.9 Hz, 1H Z), 3.81 – 3.74 (m, 6H), 3.78 – 3.68 (m, 6H), 2.59 (d,
J = 1.2 Hz, 3H), 2.49 (d, J = 1.4 Hz, 3H).
methyl 3-(3-methoxyphenyl)but-2-enoate 1H NMR (500 MHz, Chloroform-d) δ 7.57 –
7.46 (m, 2H), 7.14 – 7.02 (m, 2H), 6.99 (dd, J = 2.5, 1.8 Hz, 2H), 6.93 – 6.80 (m, 2H), 6.14
(tt, J = 1.7, 0.9 Hz, 1H E), 5.90 (d, J = 1.6 Hz, 1H Z), 3.88 – 3.76 (m, 6H), 3.75 (d, J = 0.5
Hz, 6H), 32.61 – 2.52 (m, 6H).
methyl 3-(4-methoxyphenyl)but-2-enoate H NMR (500 MHz, Chloroform-d) δ 7.96 – 7.89
(m, 1H), 7.48 – 7.40 (m, 2H), 7.22 – 7.15 (m, 1H), 6.95 – 6.82 (m, 4H), 6.11 (dq, J = 2.4,
1.3 Hz, 1H E), 5.87 (s, 1H Z), 3.87 – 3.75 (m, 3H), 3.81 (s, 43H), 3.73 (d, J = 0.9 Hz, 3H),
3.57 (d, J = 0.9 Hz, 3H), 2.58 – 2.52 (m, 6H).

3-phenylbut-2-en-1-ols General procedure for DIBAL-H Reduction on methyl
phenylbutenoates of Table 2-2: To a schlenk tube with the methyl phenylbutenoate (1.27g,
6.0 mmol, 1.0 equiv) dissolved in THF (10 ml) was added DIBAL-H (2.36 ml, 13.3 mmol,
2.2 equiv) at -78°C. The reaction mixture was stirred at -78°C for 1 hour before it was
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warmed to 0°C and then quenched with MeOH (20 ml). The reaction mixture was extracted
with EtOAc (3 x 20 ml) and the organic extracts were dried over MgSO4 and concentrated
in vacuo. Purification by column chromatography on silica (4:1 hexanes:ethyl acetate) gave
the corresponding methyl phenylbutenols in good yields (46-92%). Isolation of E and Z
isomers was possible at this stage via column chromatography.

3-(o-tolyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.23 – 7.11 (m, 4H), 7.11
– 6.97 (m, 4H), 5.74 (tq, J = 6.8, 1.5 Hz, 1H E), 5.58 – 5.50 (m, 1H Z), 4.34 (dp, J = 6.8,
0.7 Hz, 2H), 3.86 – 3.80 (m, 2H), 2.29 (s, 6H), 2.29 (d, J = 1.1 Hz, 3H), 2.22 (d, J = 0.6
Hz, 3H), 1.99 (ddq, J = 8.3, 1.4, 0.6 Hz, 3H), 1.56 – 1.52 (m, 3H).
(E)-3-(m-tolyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.30 – 7.21 (m, 1H),
7.15 – 7.07 (m, 3H), 6.00 (ddq, J = 8.0, 6.6, 1.3 Hz, 1H), 4.37 (dq, J = 6.6, 0.9 Hz, 2H),
2.39 (t, J = 0.9 Hz, 3H), 2.09 (d, J = 1.0 Hz, 3H).
(E)-3- (p-tolyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.35 – 7.27 (m, 2H),
7.18 – 7.05 (m, 2H), 5.96 (tq, J = 6.7, 1.3 Hz, 1H), 4.36 (dd, J = 6.7, 0.9 Hz, 2H), 2.35 (s,
3H), 2.07 (dt, J = 1.4, 0.8 Hz, 3H).
3-(2-chlorophenyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.41 – 7.21 (m,
2H), 7.25 – 7.12 (m, 4H), 7.14 – 7.07 (m, 2H), 5.78 (tq, J = 7.1, 1.5 Hz, 1H E), 5.61 (tq, J
= 6.6, 1.5 Hz, 1H Z), 4.32 (dt, J = 6.6, 0.7 Hz, 2H), 3.84 (d, J = 7.0 Hz, 2H), 2.40 (s, 3H).
(E)-3-(3-chlorophenyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.38 (dt, J =
2.5, 1.0 Hz, 1H), 7.32 – 7.20 (m, 3H), 5.98 (tq, J = 6.7, 1.4 Hz, 1H), 4.36 (dq, J = 6.6, 0.7
Hz, 2H), 2.11 – 2.02 (m, 3H).
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3-(4-chlorophenyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.37 – 7.23 (m,
6H), 7.14 – 7.08 (m, 2H), 5.98 – 5.91 (m, 1H, E), 4.87 (q, J = 6.5 Hz, 1H Z), 4.35 (dt, J =
6.7, 0.7 Hz, 2H), 4.04 (ddt, J = 7.0, 2.0, 1.0 Hz, 2H), 2.08 – 2.00 (m, 6H)
(Z)-3- (2-methoxyphenyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.32 – 7.21
(m, 1H), 7.17 – 7.12 (m, 1H), 6.99 – 6.85 (m, 2H), 5.69 (tq, J = 6.7, 1.4 Hz, 1H), 4.33 (dq,
J = 6.7, 0.8 Hz, 2H), 3.82 (d, J = 1.0 Hz, 3H), 2.04 (ddt, J = 7.9, 1.5, 0.9 Hz, 3H).
3-(3-methoxyphenyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.24 (t, J = 7.9
Hz, 2H), 7.00 (ddt, J = 7.7, 1.9, 1.0 Hz, 2H), 6.98 – 6.87 (m, 2H), 6.88 – 6.78 (m, 2H), 5.98
(tq, J = 6.6, 1.4 Hz, 1H E), 4.78 (dd, J = 7.0, 0.9 Hz, 1H Z), 4.36 (dq, J = 6.7, 0.9 Hz, 4H),
3.88 – 3.72 (m, 4H), 3.82 (s, 6H), 2.14 – 2.01 (m, 6H).
(E)-3-(4-methoxyphenyl)but-2-en-1-ol 1H NMR (500 MHz, Chloroform-d) δ 7.44 – 7.30
(m, 2H), 6.97 – 6.77 (m, 2H), 5.92 (tq, J = 6.8, 1.3 Hz, 1H), 4.36 – 4.27 (m, 2H), 3.81 (s,
3H), 2.05 (dt, J = 1.3, 0.7 Hz, 3H).

3-phenylbut-2-en-1-yl benzoates General procedure for benzoylation of methyl phenyl
butenols of Table 2-2: To a schlenk tube with the methyl phenylbutenol (0.10 g, 0.55 mmol,
1.0 equiv) in DCM (2.75 ml) was added pyridine (0.09 ml, 1.1 mmol, 2.0 equiv) at 0°C
before adding benzoyl chloride (0.08 ml, 0.66 mmol, 1.2 equiv). The reaction was let warm
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to room temperature as it was stirred overnight. The reaction was quenched with aqueous
NHCl4 (10 ml) and extracted with EtOAc (3 x 10 ml) and the organic extracts were dried
over MgSO4 and concentrated in vacuo. Purification by column chromatography on silica
(10:1 hexanes:ethyl acetate) gave the corresponding methyl phenylbutenyl benzoates in
greatly varying yields (3.3-99.8% yield).

3-(o-tolyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ 8.17 – 8.06 (m,
2H), 8.04 (s, 2H), 8.06 – 7.97 (m, 2H), 7.61 – 7.52 (m, 2H), 7.56 – 7.40 (m, 4H), 7.28 –
7.13 (m, 4H), 7.16 – 7.04 (m, 2H), 5.84 (tt, J = 7.1, 1.6 Hz, 1H), 5.63 (tq, J = 6.8, 1.5 Hz,
1H), 5.03 (dt, J = 6.9, 0.7 Hz, 2H), 4.53 (dq, J = 7.1, 0.9 Hz, 2H), 2.30 (d, J = 17.8 Hz,
3H), 2.11 – 2.03 (m, 3H).
(E)-3-(m-tolyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ 8.21 – 8.14
(m, 1H), 8.13 – 8.03 (m, 1H), 7.72 – 7.65 (m, 1H), 7.60 – 7.50 (m, 2H), 7.49 – 7.41 (m,
2H), 7.15 – 7.07 (m, 2H), 6.03 (tq, J = 6.9, 1.4 Hz, 1H), 5.05 (dd, J = 6.9, 0.8 Hz, 2H), 2.43
(t, J = 0.6 Hz, 1H), 2.37 (s, 3H), 2.18 (dt, J = 1.4, 0.7 Hz, 3H),
(E)-3-(p-tolyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ 8.11 – 8.02
(m, 2H), 7.60 – 7.50 (m, 2H), 7.49 – 7.38 (m, 3H), 7.42 – 7.31 (m, 3H), 7.26 (s, 2H), 7.26
– 7.06 (m, 4H), 6.02 (td, J = 6.8, 1.5 Hz, 1H), 5.04 (dt, J = 7.0, 0.7 Hz, 2H), 2.35 (s, 3H),
2.20 – 2.10 (m, 3H).
3-(2-chlorophenyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ 8.21 –
8.13 (m, 2H), 8.14 – 8.05 (m, 2H), 8.05 – 7.99 (m, 2H), 7.61 – 7.49 (m, 2H), 7.50 – 7.37
(m, 3H), 7.40 – 7.31 (m, 2H), 7.31 – 7.21 (m, 2H), 7.24 – 7.13 (m, 3H), 5.92 – 5.84 (m, 1H
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E), 5.71 (tqd, J = 6.8, 1.4, 0.6 Hz, 1H Z), 5.02 (dq, J = 6.8, 0.8 Hz, 2H), 4.59 – 4.53 (m,
2H), 2.11 (m, 6H).
(E)-3-(3-chlorophenyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ
8.11 – 8.02 (m, 2H), 7.61 – 7.50 (m, 1H), 7.49 – 7.39 (m, 3H), 7.35 – 7.22 (m, 3H), 6.05
(tq, J = 6.7, 1.4 Hz, 1H), 5.07 – 5.01 (m, 2H), 2.16 (dt, J = 1.4, 0.9 Hz, 3H).
3-(4-chlorophenyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ 8.12 –
8.02 (m, 4H), 7.61 – 7.48 (m, 2H), 7.45 (ddd, J = 9.1, 7.3, 3.7 Hz, 4H), 7.43 – 7.35 (m,
2H), 7.38 – 7.32 (m, 2H), 7.35 – 7.24 (m, 2H), 7.22 – 7.15 (m, 2H), 6.10 (q, J = 6.6 Hz,
1H E), 5.82 (td, J = 7.2, 1.5 Hz, 1H Z), 5.04 (dt, J = 6.8, 0.7 Hz, 2H), 4.73 (dt, J = 7.1, 1.1
Hz, 2H), 2.20 – 2.10 (m, 6H).
(Z)-3-(2-methoxyphenyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ
9.33 (s, 1H), 8.68 – 8.63 (m, 1H), 8.19 – 8.00 (m, 1H), 7.72 (tt, J = 7.7, 1.8 Hz, 1H), 7.60
– 7.36 (m, 2H), 7.36 – 7.29 (m, 1H), 7.17 (dd, J = 7.4, 1.8 Hz, 1H), 7.00 – 6.78 (m, 1H),
5.77 (tq, J = 6.8, 1.4 Hz, 1H), 4.64 (dt, J = 6.9, 1.1 Hz, 2H), 3.84 – 3.74 (m, 3H), 2.19 –
2.05 (m, 3H).

3-(3-methoxyphenyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ 8.14
– 8.05 (m, 4H), 7.63 – 7.53 (m, 2H), 7.50 – 7.42 (m, 6H), 7.09 – 6.98 (m, 6H), 6.93 – 6.80
(m, 4H), 6.13 (q, J = 6.6 Hz, 1H E), 6.07 (tp, J = 6.9, 1.2 Hz, 1H Z), 5.06 (dq, J = 6.8, 0.8
Hz, 2H), 4.79 (dp, J = 7.2, 1.1 Hz, 2H), 3.84 (d, J = 4.7 Hz, 6H), 2.22 – 2.13 (m, 6H).
(E)-3-(4-methoxyphenyl)but-2-en-1-yl benzoate 1H NMR (500 MHz, Chloroform-d) δ
8.11 – 8.04 (m, 2H), 7.60 – 7.52 (m, 1H), 7.48 – 7.35 (m, 4H), 6.94 – 6.84 (m, 2H), 5.98
(tt, J = 7.0, 1.3 Hz, 1H), 5.03 (dq, J = 7.0, 0.7 Hz, 2H), 3.82 (s, 3H), 2.19 – 2.10 (m, 3H).
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but-3-en-2-ylbenzenes and but-2-en-2-ylbenzenes General procedure SmI2-mediated
reductive eliminations of Table 2-2: To a schlenk tube of SmI2 (19 ml, 1.9 mmol, 7 equiv)
was added MeOH (2.2 ml, 54.4 mmol, 200 equiv) before adding either cinnamyl benzoate
or 1-phenylallyl benzoate (0.24 g, 1.0 mmol, 1.0 equiv) to the reaction flask before stirring
at room temperature overnight. The reaction was quenched with aqueous NaHCO3 (25 ml)
and extracted with EtOAc (2 x 25 ml). The organic extracts were dried over MgSO4 and
concentrated in vacuo. 1H NMR analysis of the crude reaction mixture allowed for analysis
of the ratio of ɣ:α products.

1-(but-3-en-2-yl)-2-methylbenzene and 1-(but-2-en-2-yl)-2-methylbenzene 1H NMR
(500 MHz, Chloroform-d) δ 8.12 – 7.98 (m, 2H), 7.63 – 7.51 (m, 1H), 7.52 – 7.39 (m, 2H),
7.24 – 6.97 (m, 3H), 5.98 (ddd, J = 17.2, 10.4, 6.0 Hz, 1H ɣ), 5.82 (td, J = 7.1, 1.5 Hz, 1H
α), 5.07 – 4.97 (m, 2H), 3.79 – 3.65 (m, 1H), 2.05 (s, 6H), 2.13 – 1.93 (m, 3H), 1.96 – 1.80
(m, 3H), 1.44 – 1.31 (m, 3H).
1-(but-3-en-2-yl)-3-methylbenzene and 1-(but-2-en-2-yl)-3-methylbenzene 1H NMR
(500 MHz, Chloroform-d) δ 8.12 – 8.03 (m, 1H), 7.47 (dt, J = 15.2, 7.5 Hz, 1H), 7.31 –
7.20 (m, 4H), 7.12 (s, 2H), 6.03 (d, J = 1.4 Hz, 1H ɣ), 5.07 (ddt, J = 13.9, 3.9, 1.5 Hz, 1H
α). 5.04 (d, J = 6.8 Hz, 2H), 3.75 – 3.68 (m, 1H), 2.35 (d, J = 24.3 Hz, 6H), 2.18 (d, J = 1.3
Hz, 3H), 1.95 – 1.87 (m, 3H), 1.31 – 1.24 (m, 3H).
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1-(but-3-en-2-yl)-4-methylbenzene and 1-(but-2-en-2-yl)-4-methylbenzene 1H NMR
(500 MHz, Chloroform-d) δ 8.14 – 7.94 (m, 1H), 7.66 – 7.29 (m, 5H), 7.30 – 7.08 (m, 3H),
6.02 (ddd, J = 17.1, 10.6, 5.8 Hz, 1H ɣ), 5.33 (m, 1H α), 5.16 – 5.06 (m, 2H), 3.85 – 3.63
(m, 1H), 2.10 (s, 6H), 1.98 (t, J = 1.2 Hz, 3H), 1.78 (dq, J = 6.8, 1.1 Hz, 3H), 1.35 (d, J =
7.0 Hz, 3H).
1-(but-3-en-2-yl)-2-chlorobenzene and 1-(but-2-en-2-yl)-2-chlorobenzene 1H NMR
(500 MHz, Chloroform-d) δ 8.14 – 7.94 (m, 1H), 7.66 – 7.29 (m, 5H), 7.30 – 7.08 (m, 3H),
6.02 (ddd, J = 17.1, 10.6, 5.8 Hz, 1H ɣ), 5.49 (m, 1H α), 5.16 – 5.06 (m, 2H), 3.85 – 3.63
(m, 1H), 1.98 (t, J = 1.2 Hz, 3H), 1.78 (dq, J = 6.8, 1.1 Hz, 3H), 1.29 – 1.24 (m, 3H).
(1-(but-3-en-2-yl)-3-chlorobenzene and 1-(but-2-en-2-yl)-3-chlorobenzene 1H NMR
(500 MHz, Chloroform-d) δ 8.11 (d, J = 7.7 Hz, 2H), 7.63 (t, J = 7.5 Hz, 1H), 7.52 – 7.42
(m, 2H), 7.25 – 7.12 (m, 2H), 7.13 – 7.07 (m, 1H), 6.02 – 5.92 (m, 1H ɣ), 5.88 (m, 1H α),
5.10 – 5.01 (m, 2H), 3.45 (m, 1H), 2.06 (s, 3H), 1.43 – 1.33 (m, 3H), 1.27 (t, J = 7.1 Hz,
3H).
(1-(but-3-en-2-yl)-4-chlorobenzene and 1-(but-2-en-2-yl)-4-chlorobenzene 1H NMR
(500 MHz, Chloroform-d) δ 8.10 (d, J = 7.6 Hz, 3H), 7.61 (s, 2H), 7.49 – 7.21 (m, 1H),
7.18 – 7.10 (m, 2H), 6.02 – 5.91 (m, 1H ɣ), 5.85 (dd, J = 6.9, 1.4 Hz, 1H α), 5.08 – 5.00
(m, 2H), 3.46 (q, J = 6.9 Hz, 1H), 2.07 – 1.98 (m, 3H), 1.80 (dt, J = 6.9, 1.1 Hz, 3H), 1.35
(d, J = 7.0 Hz, 3H).
1-(but-3-en-2-yl)-2-methoxybenzene and 1-(but-2-en-2-yl)-2-methoxybenzene

1

H

NMR (500 MHz, Chloroform-d) δ 8.15 – 8.01 (m, 2H), 7.60 – 7.51 (m, 1H), 7.51 – 7.39
(m, 2H), 7.23 – 7.09 (m, 1H), 7.03 – 6.80 (m, 2H), 6.06 (ddd, J = 17.2, 10.4, 6.0 Hz, 1H
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ɣ), 5.77 (tq, J = 6.8, 1.4 Hz, 1H α), 5.10 – 5.01 (m, 2H), 3.90 – 3.82 (m, 6H), 3.82 (m, 1H),
2.13 (dt, J = 1.5, 0.8 Hz, 3H), 2.13 – 1.96 (m, 3H), 1.32 (d, J = 7.0 Hz, 3H).
1-(but-3-en-2-yl)-3-methoxybenzene and 1-(but-2-en-2-yl)-3-methoxybenzene

1

H

NMR (500 MHz, Chloroform-d) δ 8.15 – 8.03 (m, 1H), 7.63 – 7.52 (m, 1H), 7.53 – 7.40
(m, 1H), 7.34 – 7.27 (m, 2H), 7.09 – 6.89 (m, 1H), 6.89 – 6.71 (m, 2H), 6.12 (q, J = 6.6
Hz, 1H α), 6.02 (ddd, J = 17.1, 10.3, 6.5 Hz, 1H ɣ), 5.12 – 5.02 (m, 2H), 3.82 (d, J = 8.0
Hz, 6H), 3.51 – 3.41 (m, 2H), 1.81 (m, 3H), 1.68 (d, J = 6.6 Hz, 3H), 1.37 (d, J = 7.0 Hz,
3H).
1-(but-3-en-2-yl)-4-methoxybenzene and 1-(but-2-en-2-yl)-4-methoxybenzene

1

H

NMR (500 MHz, Chloroform-d) δ 8.13 – 8.03 (m, 2H), 7.65 – 7.52 (m, 1H), 7.52 – 7.41
(m, 2H), 7.22 – 7.11 (m, 2H), 6.95 – 6.80 (m, 1H), 6.04 – 5.94 (m, 1H α), 5.78 (ddd, J =
13.6, 8.0, 6.5 Hz, 1H ɣ), 5.13 – 4.98 (m, 2H), 3.48 – 3.38 (m, 1H), 2.20 – 2.11 (m, 6H),
2.14 – 1.97 (m, 3H), 1.71 – 1.60 (m, 3H), 1.37 (d, J = 18.4 Hz, 3H).

(E)-2-phenylnon-2-en-4-ol (2.16) To a schlenk tube with Cp2ZrCl2 (0.052 mg, 0.176
mmol, 10 mol%) in DCM (8.8 ml) was added AlMe3 (1.76 ml, 3.5 mmol, 2.0 equiv) before
adding H2O (0.03 ml, 1.76 mmol, 1.0 equiv) dropwise at -20°C. The reaction was stirred
at room temperature for 10 minutes before cooling to 0°C and adding phenylacetylene (0.2
ml, 1.76 mmol, 1.0 equiv). The resulting mixture was stirred for 1 hour at 0°C before
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adding hexanal (0.24 ml, 1.94mmol, 1.1 equiv) and then stirring for another hour at 0°C.
The reaction was quenched with H2O (2 ml) and 1 ml HCl (1 M), and then extracted with
DCM (2 x 10 ml). The organic extracts were dried over MgSO4 and concentrated in vacuo.
Purification by column chromatography on silica (4:1 hexanes:ethyl acetate) gave
compound 2.16 (0.362 g, 94.3% yield).
1

H NMR (500 MHz, Chloroform-d) δ 8.11 – 8.03 (m, 2H), 7.61 – 7.52 (m, 1H), 7.49 – 7.39

(m, 3H), 7.37 – 7.22 (m, 2H), 5.93 (dt, J = 9.0, 6.7 Hz, 1H), 5.81 (dq, J = 9.0, 1.3 Hz, 1H),
2.23 (d, J = 1.4 Hz, 2H), 1.98 – 1.87 (m, 1H), 1.82 – 1.70 (m, 1H), 1.52 – 1.41 (m, 1H),
1.44 – 1.24 (m, 3H), 0.97 – 0.85 (m, 3H).

(E)-2-phenylnon-2-en-4-yl benzoate (2.17) To a schlenk tube with 2.16 (0.362 g, 1.66
mmol, 1.0 equiv) in DCM (8.3 ml) was added pyridine (0.27 ml, 3.32 mmol, 2.0 equiv) at
0°C before adding benzoyl chloride (0.23 ml, 1.99 mmol, 1.2 equiv). The reaction was let
warm to room temperature as it was stirred overnight. The reaction was quenched with
aqueous NHCl4 (10 ml) and extracted with MTBE (2 x 15 ml) and the organic extracts were
dried over MgSO4 and concentrated in vacuo. Purification by column chromatography on
silica (10:1 hexanes:ethyl acetate) gave 2.17 (0.349 g, 60.5%) as a colorless oil.
1

H NMR (500 MHz, Chloroform-d) δ 8.02 – 7.33 (m, 3H), 7.22-6.83 (m, 2H), 5.93 (dt, J

= 9.0, 6.7 Hz, 1H), 5.81 (dq, J = 9.0, 1.3 Hz, 1H), 2.23 (d, J = 1.4 Hz, 2H), 1.98 – 1.87 (m,
1H), 1.82 – 1.70 (m, 1H), 1.52 – 1.41 (m, 1H), 1.44 – 1.24 (m, 3H), 0.97 – 0.85 (m, 3H).
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(E)-non-2-en-2-ylbenzene (2.18) and (E)-non-3-en-2-ylbenzene (2.19) To a schlenk tube
of a SmI2 solution in THF (25 ml, 0.1 M, 7 equiv) was added MeOH (2.9 ml, 72 mmol,
200 equiv) before adding compound 2.17 (0.116 g, 0.36 mmol, 1.0 equiv) to the reaction
flask before stirring at room temperature for 1 hour. The reaction was quenched with
aqueous NaHCO3 (25 ml) and extracted with EtOAc (2 x 25 ml). The organic extracts were
dried over MgSO4 and concentrated in vacuo. Purification by column chromatography on
silica (10:1 hexanes:ethyl acetate) gave a 9:1 mixture of 2.18 and 2.19 (0.081 g,
quantitative yield).

Signals for compound 2.18: 1H NMR (500 MHz, Chloroform-d) δ 7.49 – 7.34 (m, 1H),
7.38 – 7.27 (m, 3H), 7.31 – 7.14 (m, 3H), 7.10 (s, 1H), 5.61 (ddt, J = 15.3, 6.7, 1.3 Hz, 1H),
5.53 – 5.39 (m, 1H), 3.44 (p, J = 7.0 Hz, 1H), 2.08 – 1.96 (m, 2H), 1.50 – 1.18 (m, 9H),
0.96 – 0.79 (m, 3H).

1-(3-bromo-4-methoxyphenyl)allyl benzoate (3.6) To a schlenk tube of 3-bromo-4methoxybenzaldehyde (2.15 g, 10 mmol, 1.0 equiv) in THF (10 ml) was added vinyl
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magnesium bromide (13 ml, 13 mmol, 1.3 equiv) at 0°C. The reaction mixture was stirred
for one hour before adding benzoyl chloride (2.03 ml, 15 mmol, 1.5 equiv) and then stirring
at 0°C overnight. The reaction mixture was quenched with aqueous NaHCO3 (25 ml) and
extracted with EtOAc (2 x 25ml). The organic extracts were dried over MgSO4 and
concentrated in vacuo. Purification by column chromatography on silica (10:1
hexanes:ethyl acetate) gave compound 3.6 (3.12 g, 90% yield) as a viscous yellow oil.
1

H NMR (500 MHz, Chloroform-d) δ 8.15 (ddd, J = 18.6, 8.4, 1.4 Hz, 1H), 8.12 – 7.93 (m,

2H), 7.73 – 7.62 (m, 1H), 7.66 – 7.40 (m, 5H), 7.44 – 7.33 (m, 1H), 6.90 (dd, J = 8.5, 4.6
Hz, 1H), 6.51 – 6.41 (m, 1H), 6.09 (ddd, J = 17.1, 10.5, 5.6 Hz, 1H), 5.32 (dt, J = 10.5, 1.3
Hz, 1H), 5.27 (s, 1H), , 3.94 – 3.76 (m, 3H).

1-(5-bromo-2-methoxyphenyl)allyl benzoate (3.3) To a schlenk tube of 5-bromo-2methoxybenzaldehyde (2.15 g, 10 mmol, 1.0 equiv) in THF (10 ml) was added vinyl
magnesium bromide (13 ml, 13 mmol, 1.3 equiv) at 0°C. The reaction mixture was stirred
for one hour before adding benzoyl chloride (2.03 ml, 15 mmol, 1.5 equiv) and then stirring
at 0°C overnight. The reaction mixture was quenched with aqueous NaHCO3 (25 ml) and
extracted with EtOAc (2 x 25 ml). The organic extracts were dried over MgSO4 and
concentrated in vacuo. Purification by column chromatography on silica (10:1
hexanes:ethyl acetate) gave compound 3.3 (3.19 g, 92% yield) as a viscous yellow oil.
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1

H NMR (500 MHz, Chloroform-d) δ 8.14 – 8.00 (m, 4H), 7.65 – 7.28 (m, 6H), 6.87 – 6.71

(m, 1H), 6.08 (ddd, J = 17.1, 10.5, 5.4 Hz, 1H), 5.39 – 5.31 (m, 1H), 5.25 (dt, J = 10.4, 1.3
Hz, 1H), 3.85 (d, J = 3.7 Hz, 3H).

4-allyl-2-bromo-1-methoxybenzene (3.5) To a schlenk tube of freshly prepared SmI2 (35
ml, 3.5 mmol, 7 equiv) was added MeOH (4.04 ml, 100 mmol, 200 equiv) before adding
compound 3.6 (0.174 g, 0.5 mmol, 1.0 equiv) to the reaction flask before stirring at room
temperature for 1 hour. The reaction was quenched with aqueous NaHCO3 (30 ml) and
extracted with EtOAc (2 x 30 ml). The organic extracts were dried over MgSO4 and
concentrated in vacuo. Purification by column chromatography on silica (10:1
hexanes:ethyl acetate) gave 3.5 (0.113 g, quantitative yield) as a pale yellow oil.
1

H NMR (500 MHz, Chloroform-d) δ 7.48 – 7.40 (m, 1H), 7.41 – 7.34 (m, 1H), 7.08 (dd,

J = 8.3, 2.2 Hz, 1H), 5.92 (ddt, J = 17.9, 9.2, 6.7 Hz, 1H), 5.27 (s, 1H), 5.11 – 5.03 (m,
1H), 3.94 – 3.82 (m, 3H), 3.31 (dd, J = 6.8, 1.5 Hz, 2H).

2-allyl-4-bromo-1-methoxybenzene (3.2) To a schlenk tube of SmI2 (35 ml, 3.5 mmol, 7
equiv) was added MeOH (4.04 ml, 100 mmol, 200 equiv) before adding compound 3.3
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(0.174 g, 0.5 mmol, 1.0 equiv) to the reaction flask before stirring at room temperature for
1 hour. The reaction was quenched with aqueous NaHCO3 (30 ml) and extracted with
EtOAc (2 x 30 ml). The organic extracts were dried over MgSO4 and concentrated in vacuo.
Purification by column chromatography on silica (10:1 hexanes:ethyl acetate) gave 3.2
(0.114 g, quantitative yield) as a pale yellow oil.
1

H NMR (500 MHz, Chloroform-d) δ 8.15 – 8.06 (m, 1H), 7.54 – 7.35 (m, 1H), 6.82 – 6.58

(m, 1H), 6.28 – 6.18 (m, 1H), 5.95 (ddt, J = 17.8, 9.2, 6.6 Hz, 1H), 5.11 – 5.03 (m, 2H),
3.90 – 3.69 (m, 3H), 3.35 (dt, J = 6.7, 1.6 Hz, 2H).

4,6'-dimethoxy-[1,1'-biphenyl]-3,3'-dicarbaldehyde (3.9) One Step Method: To a
schlenk tube with 3.4 (1.0 g, 4.65 mmol, 1.0 equiv) in p-dioxane (18.6 ml) was added
KOAc (1.37 g, 13.95 mmol, 3.0 equiv) and bis-pinacolatodiboron (1.18 g, 4.65 mmol, 1.0
equiv). The reaction mixture was then degassed by bubbling nitrogen through the solution
for 5 minutes before adding Pd(dppf)Cl2 (0.205 g, 0.28 mmol, 6 mol%) and then stirring
at 90°C for 24 hours. The reaction mixture was then cooled to room temperature and 3.7
(1.0 g, 4.65 mmol, 1.0 equiv) was added to the flask. Pd(tBu3)2 (0.36 g, 0.7 mmol, 15
mol%) was then added before adding a solution of Na2CO3 (1.48 g, 13.95 mmol, 3.0 equiv)
in H2O (2 ml). The reaction was stirred at 70°C for 24 hours and then quenched with H2O
(20 ml) and extracted with EtOAc (3 x 25 ml). The organic extracts were dried over
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MgSO4, filtered over celite, and concentrated in vacuo. Purification by column
chromatography on silica (10:1 hexanes:ethyl acetate) gave 3.9 (1.45 g, quantitative yield)
as a pale yellow crystalline solid.

Two step method: To a schlenk tube with 3.4 (1.0 g, 4.65 mmol, 1.0 equiv) in p-dioxane
(18.6 ml) was added KOAc (1.37 g, 13.95 mmol, 3.0 equiv) and bis-pinacolatodiboron
(1.18 g, 4.65 mmol, 1.0 equiv). The reaction mixture was then degassed by bubbling
nitrogen through the solution for about 5 minutes before adding Pd(dppf)Cl2 (0.21 g, 0.028
mmol, 6 mol%) and then stirring at 90°C for 24 hours. The reaction mixture was then
cooled to room temperature before filtering through celite and concentrating in vacuo. To
the boronate ester 3.10 (1.22 g, 4.65 mmol, 1.2 equiv) in p-dioxane (18.6 ml) was added
3.7 (0.80 g, 3.72 mmol, 1.0 equiv) and Pd(tBu3)2 (0.36 g, 0.7 mmol, 15 mol%), followed
by the addition of the solution of Na2CO3 (1.48 g, 13.95 mmol, 3.0 equiv) in H2O (2 ml).
The reaction was stirred at 70°C for 24 hours and then quenched with H2O (20 ml) and
extracted with EtOAc (3 x 25 ml). The organic extracts were dried over MgSO4, filtered
over celite, and concentrated in vacuo. Purification by column chromatography on silica
(10:1 hexanes:ethyl acetate) gave 3.9 (0.887 g, 73.5%) as a pale yellow crystalline solid.
1

H NMR (500 MHz, Chloroform-d) δ 10.50 (t, J = 0.9 Hz, 1H), 9.92 (t, J = 0.9 Hz, 1H),

8.00 (dt, J = 2.3, 0.9 Hz, 1H), 7.89 – 7.80 (m, 2H), 7.73 (ddd, J = 8.6, 2.4, 0.8 Hz, 1H),
7.07 (dd, J = 12.0, 8.6 Hz, 2H), 3.98 (t, J = 0.8 Hz, 3H), 3.90 (d, J = 1.0 Hz, 3H). 13C NMR
(126 MHz, Chloroform-d) δ 190.82, 190.80, 189.63, 161.37, 161.27, 161.24, 136.88,
131.96, 131.52, 131.47, 129.95, 129.77, 129.62, 129.55, 129.52, 124.50, 111.54, 111.10,
77.22, 76.96, 76.55, 56.03, 56.02, 55.90, 55.83, 29.06.
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1,1'-(4,6'-dimethoxy-[1,1'-biphenyl]-3,3'-diyl)bis(prop-2-en-1-ol) (3.11) To a solution
of 3.9 (.208 g, 0.77 mmol, 1.0 equiv) in THF (7.7 ml) was added vinyl magnesium chloride
(5.4 ml, 5.4 mmol, 4 equiv) at 0°C. The reaction was stirred for 1 hour before quenching
with aqueous NHCl4 (15 ml) and extracting with EtOAc (3 x 15 ml). The organic extracts
were dried over MgSO4 and concentrated in vacuo. Purification by column
chromatography on silica (10:1 hexanes:ethyl acetate) gave the alcohol 3.11 (0.178 g, 71%
yield) as a white solid.
1

H NMR (500 MHz, Chloroform-d) δ 7.48 – 7.36 (m, 3H), 7.29 – 7.21 (m, 1H), 6.93 – 6.85

(m, 2H), 6.12 (m, 1H), 6.03 (m, 1H), 5.42 (d, J = 5.6 Hz, 1H), 5.30 (dt, J = 17.5, 1.7 Hz,
1H), 5.16 – 5.09 (m, 2H), 3.84 (s, 3H), 3.75 (s, 3H). 13C NMR (126 MHz, Chloroform-d)
δ 156.09, 155.93, 140.29, 139.42, 134.97, 130.93, 130.29, 130.28, 130.00, 129.79, 128.97,
128.73, 126.28, 114.88, 114.61, 111.27, 110.41, 109.92, 75.03, 74.94, 71.86, 55.72, 55.53.
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(4,6'-dimethoxy-[1,1'-biphenyl]-3,3'-diyl)bis(prop-2-ene-1,1-diyl) dibenzoate (3.8) To
a schlenk tube with 3.11 (1.05 g, 3.24 mmol, 1.0 equiv) in DCM (8.3 ml) was added
pyridine (1.3 ml, 16.2 mmol, 5.0 equiv) at 0°C before adding benzoyl chloride (1.13 ml,
9.7 mmol, 3.0 equiv). The reaction was let warm to room temperature as it was stirred
overnight. The reaction was quenched with aqueous NHCl4 (15 ml) and extracted with
EtOAc (3 x 15 ml) and the organic extracts were dried over MgSO4 and concentrated in
vacuo. Purification by column chromatography on silica (4:1 hexanes:ethyl acetate) gave
3.8 (2.0 g, quantitative yield) as a colorless oil.
1

H NMR (500 MHz, Chloroform-d) δ 8.20 – 8.13 (m, 4H), 8.16 – 8.05 (m, 2H), 7.68 (ddt,

J = 8.8, 7.1, 1.3 Hz, 1H), 7.59 – 7.35 (m, 5H), 7.00 – 6.91 (m, 4H), 6.21 – 6.08 (m, 2H),
5.48 – 5.19 (m, 4H), 3.90 (s, 1H), 3.70 (s, 1H).

3',5-diallyl-2,4'-dimethoxy-1,1'-biphenyl (3.1) To a schlenk tube with a freshly prepared
SmI2 solution in THF (675 ml, 0.1 M, 18 equiv) was added MeOH (30.4 ml, 100 mmol,
200 equiv) before adding compound 3.8 (2.0 g, 3.24 mmol, 1.0 equiv) to the reaction flask
before stirring at room temperature for 1 hour. The reaction was quenched with aqueous
NaHCO3 (250 ml) and extracted with EtOAc (2 x 200 ml). The organic extracts were dried

63

over MgSO4 and concentrated in vacuo. Purification by column chromatography on silica
(10:1 hexanes:ethyl acetate) gave 3.1 (0.932 g, 97.7%) as a white crystalline solid.
1

H NMR (500 MHz, Chloroform-d) δ 7.37 (dd, J = 8.4, 2.3 Hz, 1H), 7.31 (d, J = 2.2 Hz,

1H), 7.16 – 7.07 (m, 2H), 6.90 (d, J = 8.3 Hz, 2H), 6.10 – 5.93 (m, 2H), 5.14 – 5.01 (m,
4H), 3.87 (s, 3H), 3.79 (s, 3H), 3.40 (dd, J = Hz, 4H). 13C NMR (126 MHz, Chloroform-d)
δ 156.36, 154.87, 137.80, 137.01, 132.21, 130.98, 130.97, 130.67, 130.44, 128.52, 128.35,
128.31, 128.05, 127.86, 126.96, 126.30, 125.48, 115.51, 115.45, 115.36, 111.27, 110.58,
109.91, 55.71, 55.47, 39.41, 34.42, 34.33, 31.93, 29.70, 29.66.

Honokiol To a schlenk tube with 3.1 (0.015 g, 0.051 mmol, 1.0 equiv) in DCM (0.05 ml)
was added BARF (0.0026 g, 0.0051 mmol, 10 mol%) followed by triethyl silane (0.025
ml, 0.154 mmol, 3.0 equiv). The reaction mixture was stirred for 20 minutes at room
temperature before it was quenched with Et3N (0.05 ml). The reaction mixture was then
filtered through celite and concentrated in vacuo. The crude silyl ether was then transferred
to a schlenk tube with THF (1.0 ml) and then TBAF (0.462 ml, 0.462 mmol, 9.0 equiv)
was added and the reaction mixture was stirred at room temperature for 30 minutes. The
reaction was quenched with H2O (5 ml) and extracted with EtOAc (3 x 10 ml). The organic
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extracts were dried over MgSO4, filtered through celite, and concentrated in vacuo.
Purification by column chromatography on silica (10:1 hexanes:ethyl acetate) gave
honokiol (0.0077 g, 57.8%) as a white crystalline solid.
1

H NMR (500 MHz, Chloroform-d) δ 7.38 – 7.12 (m, 2H), 7.08 – 6.98 (m, 2H), 6.91 (dd,

J = 9.7, 8.1 Hz, 2H), 6.12 – 5.91 (m, 2H), 5.26 – 5.15 (m, 2H), 5.13 – 5.02 (m, 2H), 3.46
(dt, J = 6.5, 1.6 Hz, 2H), 3.35 (m, 2H).
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